Unilever PLC Earnings - Q3 2026 Analysis & Highlights
Unilever reported strong volume-led growth, broad strength in HPC and emerging markets, higher input-cost pressure, and an upgraded 2026 outlook; the call also covered competitive challenges in US Foods and plans to separate the Foods business.
Key financial results
Third-quarter turnover was €13.3 billion, up 6.7%; underlying sales growth (USG) was 5.2%, comprising 2.9% volume and 2.3% price growth.
For the first nine months, USG was 4.9%, with volume growth of 3.8%.
Acquisitions, mainly Grüns and Dr. Squatch, added 1.4% to turnover, disposals reduced it by 0.6%, and currency was neutral in the quarter.
The company confirmed its expectation of hard-currency earnings growth and modest underlying operating-margin improvement for 2026; it did not provide quarterly EPS or operating-profit figures in the remarks.
Business segment results
Beauty and Wellbeing grew 5.7%, with volume up 3.6% and price up 2.1%; Beauty grew 7.5%, while Wellbeing declined high-single-digit in the quarter and was down 1% year to date.
Personal Care grew 6.3%, with volume up 3.8% and price up 2.4%; growth was broad-based, with high-single-digit growth in emerging markets and mid-single-digit growth in the US.
Home Care grew 9.1%, with volume up 5.4% and price up 3.6%; India and Brazil each delivered double-digit volume growth.
Foods grew 0.1%, with volume down 1.1% and price up 1.3%; emerging markets and Unilever Food Solutions grew, offset by developed-market retail declines.
The three HPC business groups—Beauty and Wellbeing, Personal Care and Home Care—each grew volume about 3%; HPC overall grew 7% in the quarter, with 4.1% from volume.
Power Brands, representing around 79% of turnover, grew 5.8%, with 3.3% from volume; 10 grew double-digit in the quarter.
Emerging markets grew 9.5%, with volume up 6%; India grew 15%, while Latin America grew 8.5%. Developed markets declined 0.9%.
North America declined 0.7% in the quarter, while Europe declined 1.7%.
Capital allocation
The company said proceeds from the planned Foods transaction would be used in part to pay down debt and manage the balance sheet; it expects no need to refinance long-term debt and is focused on managing short-term commercial paper.
Management indicated that a bond issuance would be considered, if needed, in 2028 and maintained net interest cost guidance of around 3% for next year.
The call did not provide specific updates on dividends, share repurchases or capital expenditure plans.
Industry trends and dynamics
Consumer conditions remained mixed across markets, with developed markets soft and Europe particularly subdued; management also cited increasing promotional intensity in parts of Europe.
Management said the wellbeing segments in which Unilever competes are growing at a high-single-digit rate, despite the company’s weaker performance this year.
The hydration-powder market was described as growing high-single-digit, with increasing share in Walmart, Amazon and grocery channels.
Unilever cited inflation in commodities, logistics and foreign exchange as cost pressures, and said geopolitical risk premiums were contributing to market uncertainty.
Management said palm and other vegetable-oil costs remained elevated and flagged potential El Niño-related pressure in the second half of 2027.
Competitive landscape
Unilever said it continued to gain value and volume share in most Home Care markets, attributing performance to its brands, R&D and supply-chain resilience.
Management described local competitors in Home Care as reducing investment and being cautious on pricing, which Unilever said created an opportunity for share gains.
In US condiments, management cited value players expanding national distribution and competition in premium mayonnaise, including avocado-oil offerings; Unilever is responding with innovation, pricing corrections and a new price-pack architecture for Hellmann’s.
Management said Dove’s US growth and market position supported its deodorant leadership, while Dove and other brands also helped drive growth in skin cleansing.
In emerging markets, Unilever cited significant share gains in categories including hair care and laundry in India, and laundry and deodorants in Brazil.
Macroeconomic environment
Unilever raised its estimate of 2026 inflation to about €900 million, from an earlier midpoint estimate of €850 million.
For 2027, management estimated inflation of €700 million to €1 billion, equivalent to about 2.5%–3.5% of the cost base, while emphasizing the uncertainty around the range.
Management expected 2027 HPC inflation to be lower than in 2026, while Foods inflation was likely to be higher.
Based on October spot rates, the company expected the full-year currency impact to be about -2% on turnover and around -30 basis points on underlying operating margin.
Management cited crude prices above $105 in September and October and later referenced a spot price of about $114, alongside geopolitical and logistics risks.
Management said Brazil’s currency had devalued in recent days but noted that it had appreciated significantly over the year; it saw no particularly negative impact on Unilever’s Brazil performance going forward.
Growth opportunities and strategies
Management described its approach as performing while transforming, with Desire at Scale, stronger brands, superior innovation and sharper execution as strategic priorities.
Unilever said Power Brands had increased from 70% of revenue in 2023 to close to 80%, reflecting its strategy to concentrate investment behind brands with strong equities and the ability to travel across geographies.
The company highlighted innovation platforms including Omo Wonder Wash, now in over 40 markets, and Cif Infinite Clean, available in eight markets.
Management said it was rebalancing Wellbeing’s exposure away from club channels and expanding in other channels; it expected sequential improvement versus Q3.
Unilever and McCormick were progressing the Foods separation, including carve-out accounts, regulatory work and transition-service arrangements; management said the transaction was on track and aimed to complete before the first half of 2027.
Financial Guidance and Outlook
Unilever maintained its 2026 full-year USG range of 4%–6%, raised its expected full-year underlying volume growth to at least 3%, and forecast second-half USG of around 5%.
The company reaffirmed its expectation of hard-currency earnings growth and modest underlying operating-margin improvement versus the 20% margin in 2025.
Management expected pricing to be higher in Q4 than in Q3 and said pricing in 2027 would be higher than the 2026 average, while emphasizing its ambition to sustain at least 2% volume growth over the medium term.
Management expected North America to return to growth in Q4 and stated that it expected the US business to be positive in that quarter.
Management expected Wellbeing to improve in Q4 and to grow ahead of its markets from the second half of 2027.
Management expected 2027 inflation of €700 million to €1 billion and said it remained committed to hard-currency earnings growth on a multi-year basis.
